Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2003
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030187004 Central nervous system disorders; Alzheimer's disease
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003US20030186990 Prodrugs of hiv replication inhibiting pyrimidines
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186984 Substituted cyclohexane derivatives
10/02/2003US20030186977 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
10/02/2003US20030186972 Isoquinolone inhibitors of factor Xa
10/02/2003US20030186969 Benzodiazepine derivatives
10/02/2003US20030186968 Psychological disorders; central nervous system disorders
10/02/2003US20030186966 Antiinflammatory agents; autoimmune disease; antiallergens
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186963 Central nervous system disorders; cardiovascular disorders
10/02/2003US20030186961 Central nervous system disorders; vision defects
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030185908 Monoamine oxidase (MAO) inhibitors and uses thereof
10/02/2003US20030183123 Organic compounds
10/02/2003CA2761440A1 Fredericamycin derivatives
10/02/2003CA2488161A1 Novel aminobenzamide derivative
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2479887A1 Piperidine or 8-aza-bicyclo¬3.2.1|oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003CA2479150A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003CA2477771A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003CA2477091A1 1,2-dihydropyrazol-3-ones as cytokine mediators
10/01/2003EP1348705A2 Alkylene-tethered bis-nitroiminoimidazolidines, process for preparing the same, and insecticides containing the same
10/01/2003EP1348704A1 Indole derivatives as 5-HT2C antagonists, process for their preparation and pharmaceutical compositions containing them
10/01/2003EP1348698A1 Substituted carboxylic acid derivatives
10/01/2003EP1348695A1 Derivatives of paraphenylene diamine with pyrrolidine groups substituted by cationic radicals and their use for dyeing keratinic fibre
10/01/2003EP1348434A1 Use of pyridyl amides as inhibitors of angiogenesis
10/01/2003EP1347967A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347965A1 New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
10/01/2003EP1347957A1 Delta 1-pyrrolines used as pesticides
10/01/2003EP1347955A1 New mandelic acid derivatives and their use as throbin inhibitors
10/01/2003EP1347784A2 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
10/01/2003EP1071665B1 Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes
10/01/2003EP0998473B1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
10/01/2003EP0944595B1 5-cyclo indole compounds as 5-ht1d receptor ligands
10/01/2003EP0920426B1 New thiazole derivatives with phosphodiesterase-inhibiting effect
10/01/2003EP0891331B1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/01/2003EP0813525B1 Benzamidine derivatives their preparation and their use as anti-coagulants
10/01/2003CN1446214A Cinnoline compounds
10/01/2003CN1446212A Quinoline derivatives having VEGF inhibiting activity
10/01/2003CN1446211A Indole derivatives useful for treatment of CNS disorders
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446200A Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents
10/01/2003CN1446199A New amidino derivatives and their use as thrombin inhibitors
10/01/2003CN1446048A N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
10/01/2003CN1445226A New cornpound derivated from quinazoline, itd preparation method and medicinal composite containig them
10/01/2003CN1122666C New 2,3-dioxide indanol compounds, process for their preparation and pharmaceutical compositions containing them
09/2003
09/30/2003US6627755 Quinazolin-4-one AMPA antagonists
09/30/2003US6627650 An isomer thereof, or an addition salt thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti- cancer agents.
09/30/2003US6627646 Dissolving norastemizole in a solvent at a temperature between 70 degrees C. and 110 degrees C.; adding an amount of nonsolvent sufficient to initiate crystallization at a temperature above 70 degrees C.;stirring
09/30/2003US6627645 Muscarinic agonists
09/30/2003US6627644 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
09/30/2003US6627634 Antitumor agents, treatment of the lungs and respiratory tract
09/30/2003US6627629 Useful for the treatment or prevention of asthma and other allergic diseases.
09/30/2003US6627628 Cardiovascular diseases such as hypertension, angina pectoris, heart failure, thrombosis and atherosclerosis. The compounds of formula (I) are able to modulate the body's own production of cyclic guanosine monophosphate (cGMP) and are suitable for
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003US6627624 Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome,
09/30/2003CA2279796C Process for the preparation of substituted pyridines
09/25/2003WO2003078541A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
09/25/2003WO2003078422A1 Novel pyridone derivative
09/25/2003WO2003078420A2 Process for making chiral 1,4-disubstituted piperazines
09/25/2003WO2003078404A1 Pyrimidine derivatives
09/25/2003WO2003078403A2 Derives d’aminoindazoles comme inhibiteurs de proteine-kinase
09/25/2003WO2003078402A1 Indazoles substituted with an anti-cancerous activity
09/25/2003WO2003078400A1 Neurotensin active 2,3-diaryl-pyrazolidine derivatives
09/25/2003WO2003078398A1 NON-PEPTIDE GnRH ANTAGONISTS
09/25/2003WO2003078397A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
09/25/2003WO2003078394A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
09/25/2003WO2003078358A2 Use of microfabricated devices for radiosynthesis
09/25/2003WO2003077921A1 Azinylaminoazoles as inhibitors of protein kinases
09/25/2003WO2003077918A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
09/25/2003WO2003077914A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003WO2003077907A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003WO2003077892A2 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for treating ang ii-mediated diseases
09/25/2003WO2003077855A2 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003077656A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
09/25/2003WO2002060392A3 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
09/25/2003WO2002036573B1 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
09/25/2003US20030181728 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
09/25/2003US20030181719 Novel heterocyclic antibacterial compounds
09/25/2003US20030181718 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/25/2003US20030181716 Novel azepane derivatives
09/25/2003US20030181497 Heterocyclic acridone inhibitors of IMPDH enzyme
09/25/2003US20030181496 Having Transforming Growth Factor- beta inhibitory activity and being useful as fibrosis inhibitors for organs or tissues
09/25/2003US20030181488 Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
09/25/2003US20030181487 Salts of benzimidazole compound and use thereof
09/25/2003US20030181485 A (2-methyl-3-pyridinyl)oxy)-3-pyridinyl)urea derivatives for treatment of a disease or disorder of the central nervous system, medical diagnosis
09/25/2003US20030181482 Antitumor agents, anticarcinogenic agents, a 3-oxoacetamideindolyl compounds, for treating cancer, cytotoxic, and angiogensis inhibitors
09/25/2003US20030181481 Therapeutic drugs for treating central nervous system disorders
09/25/2003US20030181474 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/25/2003US20030181472 Inflammation modulators
09/25/2003US20030181470 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors
09/25/2003US20030181465 Pyrimidines as novel openers of potassium ion channels
09/25/2003US20030181452 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate
09/25/2003US20030181446 Novel N-acylated heterocycles
09/25/2003US20030181440 Isonipecotamides for the treatment of integrin-mediated disorders
1 ... 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 ... 1080